Qube Research & Technologies (QRT)
TSHA icon

Qube Research & Technologies (QRT)’s Taysha Gene Therapies TSHA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-352,684
Closed -$709K – 3831
2024
Q3 		$709K Sell
352,684
-279,816
-44% -$614K ﹤0.01% 2155
2024
Q2 		$1.42M Sell
632,500
-439,570
-41% -$1.28M ﹤0.01% 1757
2024
Q1 		$3.08M Buy
1,072,070
+953,549
+805% +$1.99M ﹤0.01% 1505
2023
Q4 		$210K Buy
+118,521
New +$236K ﹤0.01% 2769
2022
Q4 		– Sell
-16,000
Closed -$31K – 3005
2022
Q3 		$31K Sell
16,000
-1,836
-10% -$6.67K ﹤0.01% 2233
2022
Q2 		$66K Buy
+17,836
New +$70.8K ﹤0.01% 2065

Other funds holding TSHA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TSHA Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of Taysha Gene Therapies (TSHA) in Q4 2024, closing a stake of 352,684 shares — an estimated $709K sold.

Qube Research & Technologies (QRT) first reported a position in TSHA in Q2 2022 and held it in 6 quarters. The position peaked at $3.08M in Q1 2024. 131 funds tracked by Wall St. Rank hold TSHA as of Q4 2024.

  • Qube Research & Technologies (QRT) reported no remaining Taysha Gene Therapies position as of Q4 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 352,684 Taysha Gene Therapies shares in Q4 2024, an estimated $709K.
  • Qube Research & Technologies (QRT) first reported a position in Taysha Gene Therapies in Q2 2022 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Taysha Gene Therapies position peaked at $3.08M in Q1 2024.
  • 131 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.